Biotech VC slump continues in Q3, says report


The markets are still stacked against startups in the American biotech sector, per a new report from PitchBook and the National Venture Capital Association.

Previous Dallas developer plans high-end RV park at Calaveras Lake
Next New subdivision plans fuel Moore County's explosive growth